SCHEMBL10144544

SCHEMBL10144544

COc1cc(C(=O)NC2CCN(CC[C@H](N)C(=O)OC3CCCC3)C2)ccc1N

nearest known ligand 0.47

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
MCHR1 Q99705 3/20 0.47
HTR4 Q13639 4/20 0.47
UTS2R Q9UKP6 1/20 0.46
CHRM4 P08173 1/20 0.43
CHRM5 P08912 1/20 0.43
ADRA2C P18825 1/20 0.43
CHRM3 P20309 1/20 0.43
HTR1D P28221 1/20 0.43
ADRA1B P35368 1/20 0.43
HTR2B P41595 1/20 0.43
HTR3A P46098 1/20 0.43
DRD4 P21917 2/20 0.43
HRH1 P35367 1/20 0.42
CCR3 P51677 1/20 0.42
KCNH2 Q12809 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13261137 1.00 MCHR1 (0.47) MCHR1HTR4UTS2RCHRM4CHRM5
SCHEMBL10143828 0.96 HTR4 (0.49) MCHR1HTR4CHRM4CHRM5ADRA2C
SCHEMBL14216102 0.88 HTR4 (0.44) HTR4CHRM4CHRM5ADRA2CCHRM3
SCHEMBL14216100 0.85 HRH2 (0.45) MCHR1HTR4UTS2RHRH1
SCHEMBL10143824 0.82 PDE4A (0.51) HTR4HRH1CCR3KCNH2
SCHEMBL10143788 0.82 PDE4A (0.51) HTR4HRH1CCR3KCNH2
SCHEMBL10143833 0.81 CACNA1B (0.44) MCHR1HTR4CHRM4CHRM5ADRA2C
SCHEMBL3936747 0.80 HTR4 (0.57) MCHR1HTR4CHRM4CHRM5ADRA2C
SCHEMBL3548018 0.80 HTR4 (0.57) MCHR1HTR4CHRM4CHRM5ADRA2C
SCHEMBL13667333 0.79 HTR4 (0.49) MCHR1HTR4CHRM4CHRM5ADRA2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2079743-B1 PTERIDINE DERIVATIVES AS POLO-LIKE KINASE INHIBITORS USEFUL IN THE TREATMENT OF CANCER CHROMA THERAPEUTICS LTD (GB) 2012-01-25 EP disclosed
WO-2008050096-A1 PTERIDINE DERIVATIVES AS POLO-LIKE KINASE INHIBITORS USEFUL IN THE TREATMENT OF CANCER CHROMA THERAPEUTICS LTD. (GB) 2008-05-02 WO disclosed